Search Tag: antimicrobial resistance

ICU Management

Environmental-sustainability-and-antimicrobials

2024 06 Feb

  Healthcare's environmental sustainability has become a pressing concern, with hospitals, clinical services, and the pharmaceutical industry identified as key contributors to environmental impact. Hospitals, in particular, are responsible for most greenhouse gas emissions, with the ICU being a significant consumer of resources like electricity,...Read more

ICU Management

Towards-artificial-intelligence-as-a-decision-support-tool-to-combat-amr-in-the-icu

2023 13 Oct

Ongoing research and challenges regarding the use of Artificial Intelligence and Machine Learning to leverage data and identify complex interactions to address antimicrobial resistance in the ICU.     The possibilities of artificial intelligence (AI), and more specifically, machine learning (ML), are being researched across almost all domains...Read more

ICU Management

4th-world-sepsis-congress

2023 25 Apr

Find World Sepsis Day on Social Media   Read more

ICU Management

Measuring-global-response-to-antimicrobial-resistance

2023 24 Jan

In order to evaluate current progress and future planning to overcome antimicrobial resistance, it is important to understand strategic commitments and policy responses. The most important mechanism guiding national strategy and action for antimicrobial resistance governance is the national action plans (NAPs). Several NAPs have been developed, but...Read more

ICU Management

Rapid-diagnostics-and-antimicrobial-resistance-in-the-icu

2022 14 Oct

The need to address the problem of antimicrobial resistance, the importance of faster diagnosis of bacterial infections and an overview of rapid diagnostic testing. Antimicrobial resistance (AMR) is rapidly increasing on a global scale. The discovery of penicillin revolutionised the field of medicine, providing safe harbour from the most...Read more

ICU Management

Reducing-antibiotic-resistance-in-the-icu

2022 14 Oct

This article reviews practices currently available to reduce the spread of antimicrobial resistance and novel therapies that are presently being developed. Introduction Among healthcare providers, and especially among those working with intensive care unit (ICU) patients, one of the greatest concerns that has emerged in recent decades has...Read more

Executive Health Management

Improving-antimicrobial-stewardship-programmes

2022 29 Aug

Researchers at Intermountain Healthcare have conducted a survey to identify and stratify antimicrobial stewardship programmes into four different groups to study the effectiveness of these models to best enhance patient care and reduce the rise of antibiotic resistance. The results are published in  Clinical Infectious Diseases . Antimicrobial...Read more

ICU Management

Sepsis-in-critical-care-3

2022 16 Mar

Sepsis is a leading cause of morbidity and mortality in the intensive care unit. Nearly  14 million adults and 2.5 million children  survive sepsis each year worldwide. In addition, sepsis survivors are known to experience poor long-term outcomes and often develop functional limitations thereafter. It is thus evident that the long-term impact...Read more

ICU Management

Sepsis-in-critical-care-effective-antimicrobial-strategies-in-icu

2022 16 Mar

ICU sepsis is associated with a mortality rate >25%, with nosocomial infection most lethal, and community acquired infection more common. Optimal management requires identification of the site of infection (lung, abdomen and blood stream most commonly), a focus on the likely pathogens based on risk factors for resistance, and provision of timely and...Read more

ICU Management

Pct-guided-antibiotic-stewardship-in-covid-19-patients

2020 14 Sep

Professor Michael Mansour is a physician-scientist with a research concentration in immune responses against invading pathogens. He attends on the Clinical Transplant Infectious Diseases and Immunocompromised Host Service at the Massachusetts General Hospital - Division of Infectious Diseases, where he cares for solid and stem cell transplant recipients...Read more

ICU Management

Lives2019-findings-from-the-diana-study

2019 01 Oct

Liesbet De Bus of Ghent University Hospital, Belgium, presented the findings of the DetermInants of Antimicrobial use aNd de-escalAtion (DIANA) study @ESICM #LIVES2019 in Berlin.  Dr. De Bus started off by explaining the concept of de-escalation and how it is all about finding a balance between early adequate antimicrobial therapy on the one...Read more

ICU Management

Trends-in-epidemiology-and-antimicrobial-resistance-in-intensive-care-units

2019 14 Mar

The intensive care unit has a unique environment, mainly because it treats severe and critically ill patients who require special care. Critical care patients often require high-risk surgeries, and there is also a frequent need for invasive devices such as central or peripheral venous catheters, urinary catheters or tracheal tubes, among others. This...Read more

ICU Management

Results-of-antimicrobial-stewardship-programme-implementation-in-multidisciplinary-hospital

2018 01 Jun

The interventional single-centre with historical control study was conducted in a 600-bed multidisciplinary hospital to evaluate 4 years’ results of an antimicrobial stewardship programme. We found a significant reduction in average duration of courses of antimicrobial therapy, length of stay of patients with infection in ICU, mortality in patients...Read more

ICU Management

Antimicrobial-use-for-iai-new-guidance

2016 11 Oct

Guidance on empiric antimicrobial therapy for patents with intra-abdominal infections (IAI) has been drawn up by a task force from 79 countries, the  Antimicrobials: A Global Alliance for Optimizing their Rational Use in Intra-Abdominal Infections- AGORA project. The experts recommend timely effective source control with appropriate antimicrobial therapy...Read more

Executive Health Management

Hospital-superbug-breakthrough

2015 14 Jun

A cutting-edge medical therapy has been developed by researchers at Queen’s University, Belfast that could protect patients against a lethal superbug. The treatment uses a molecule called an inhibitor and prevents the superbug Klebsiella pneumonia from blocking the body’s natural defences. Klebsiella has a mortality rate of 25 to 60 percent...Read more

Pharmacy Management

Eahp-2015-year-of-action-on-antimicrobial-resistance

2015 12 Jan

The European Association of Hospital Pharmacists (EAHP) has issued a call to policy-makers in the European Union to make 2015 a year of action with respect to the antimicrobial resistance challenge. The new policy statement published by 34 national member associations reminds policy makers of the opportunities available to them as well as highlights...Read more